Buying common medicines can push poor people further into poverty

August 31, 2010

A substantial proportion (up to 86%) of the population living in low and middle income countries would be pushed into poverty as a result of purchasing common life-saving medicines. These are the findings of a study by Laurens Niëns from Erasmus University Rotterdam and colleagues and published in this week's PLoS Medicine. In addition, generic versions of such medicine were shown to be generally substantially more affordable than originator brand products.

In order to show the impact of the cost of medicines on poorer populations, the authors analysed the proportion of people who would be pushed into poverty (an income level of US$1.25 or US$2 a day) by paying for life-saving medicines--the "impoverishing effect of a ."

The authors generated "impoverishment rates" of four medicines in 16 low- and middle-income countries by comparing households' daily per capita income before and after (the hypothetical) purchase of one of the following: a salbutamol 100 mcg/dose inhaler, glibenclamide 5 mg cap/tab, atenolol 50 mg cap/tab, and amoxicillin 250 mg cap/tab. This selection of drugs covers the treatment/management of three and one acute illness.

The results of the study show that the high cost of medicines have catastrophic effects on poor people. In addition, as the treatment of often requires a combination of medicines, the cost of treating and managing a chronic condition such as asthma, diabetes, and cardiovascular disease is likely to be even more unaffordable than what is reported in this study.

The authors conclude: "Action is needed to improve medicine affordability, such as promoting the use of quality assured, low-priced generics, and establishing health insurance systems."

More information: Niens LM, Cameron A, Van de Poel E, Ewen M, Brouwer WBF, et al. (2010) Quantifying the Impoverishing Effects of Purchasing Medicines: A Cross-Country Comparison of the Affordability of Medicines in the Developing World. PLoS Med 7(8): e1000333. doi:10.1371/journal.pmed.1000333

Related Stories

Recommended for you

Some breastfeeding advice worth ditching: US task force

October 25, 2016

A review of scientific evidence on breastfeeding out Tuesday found that some long-held advice is worth ditching, including that babies should avoid pacifiers and moms should breastfeed exclusively in the first days after ...

Sleep loss tied to changes of the gut microbiota in humans

October 25, 2016

Results from a new clinical study conducted at Uppsala University suggest that curtailing sleep alters the abundance of bacterial gut species that have previously been linked to compromised human metabolic health. The new ...


Adjust slider to filter visible comments by rank

Display comments: newest first

5 / 5 (1) Sep 01, 2010
It's their own fault for being poor, ask any republican.
not rated yet Sep 01, 2010
One could just as well 'theoretically' say they would / will be MUCH better served simply because they will be pushed towards the 'cheaper' / inexpensive / virtually free medicines such as the simple sugar d-mannitol used in Japan for example and veritably totally unused in the USA.

"D-Mannitol, Inhibits ACE Activity and Lowers the Blood Pressure of Spontaneously Hypertensive Rats"
"70% physicians in China use mannitol or glycerol in acute stroke"

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.